DOI: 10.1055/s-00037682

International Journal of Epilepsy

Referenz

Blumenthal GM, Cortazar P, Zhang JJ. et al.
FDA approval summary: sunitinib for the treatment of progressive well-differentiated locally advanced or metastatic pancreatic neuroendocrine tumors.

Oncologist
17 (08) 2012; 1108-1113

Bibliographische Angaben herunterladen

Suchen in:
Aufrufen in: